Download as pdf or txt
Download as pdf or txt
You are on page 1of 9

Aliment Pharmacol Ther 2002; 16: 197±205.

Antioxidant effects of herbal therapies used by patients


with in¯ammatory bowel disease: an in vitro study
L. LANGMEAD, C. DAW SON, C. HAWK INS, N . BANNA, S. LOO & D. S. RAMPTON
Academic Department of Adult and Paediatric Gastroenterology, Barts and the London, Queen Mary's, School of Medicine and
Dentistry, London, UK
Accepted for publication 21 August 2001

¯uorimetry to de®ne peroxyl radical scavenging using a


SUMMARY
phycoerythrin degradation assay. Chemiluminescence
Background: Herbal remedies used by patients for treat- was used to detect herbal effects on generation of
ment of in¯ammatory bowel disease include slippery oxygen radicals by mucosal biopsies from patients with
elm, fenugreek, devil's claw, Mexican yam, tormentil active ulcerative colitis.
and wei tong ning, a traditional Chinese medicine. Results: Like 5-ASA, all herbs, except fenugreek, scav-
Reactive oxygen metabolites produced by in¯amed enged superoxide dose-dependently. All materials tested
colonic mucosa may be pathogenic. Aminosalicylates scavenged peroxyl dose-dependently. Oxygen radical
(5-ASA) are antioxidant and other such agents could be release from biopsies was reduced after incubation in all
therapeutic. herbs except Mexican yam, and by 5-ASA.
Aims: To assess the antioxidant effects of herbal remed- Conclusions: All six herbal remedies have antioxidant
ies in cell-free oxidant-generating systems and in¯amed effects. Fenugreek is not a superoxide scavenger, while
human colorectal biopsies. Mexican yam did not inhibit radical generation by
Methods: Luminol-enhanced chemiluminescence in a in¯amed biopsies. Slippery elm, fenugreek, devil's claw,
xanthine/xanthine oxidase cell-free system was used to tormentil and wei tong ning merit formal evaluation as
detect superoxide scavenging by herbs and 5-ASA, and novel therapies in in¯ammatory bowel disease.

and poor quality of life associated with in¯ammatory


INTRODUCTION
bowel disease.4±6
Conventional therapies used in in¯ammatory bowel Reactive oxygen metabolites (ROM) are present in
disease are not totally successful in achieving remission excess in in¯amed colonic mucosa and are likely to play
or preventing relapse, and may cause serious side- a pathogenic role in in¯ammatory bowel disease.7±10
effects, therefore many patients seek alternative options. The antioxidant actions of aminosalicylates (5-ASA)
Indeed, surveys of patients with in¯ammatory bowel may constitute at least part of their therapeutic
disease indicate that up to half have tried or currently effect.11±13 Novel drugs or therapies for in¯ammatory
employ some form of complementary therapy, and that bowel disease that have antioxidant activity may be
this ®gure is steadily rising.1±3 The most commonly useful clinically. For example, allopurinol, a xanthine
used alternative remedies are herbal, the main reasons oxidase inhibitor, appears to be effective in pouchitis,14
cited by patients for their purchase being the chronicity and in prolonging the time to relapse in ulcerative
colitis.15 Superoxide dismutase showed encouraging
preliminary results in refractory Crohn's disease.16
Correspondence to: Dr D. S. Rampton, Endoscopy Unit, Royal London
Hospital, London E1 1BB, UK. Although many herbal concoctions are said to be
E-mail: D.Rampton@mds.qmw.ac.uk effective in chronic in¯ammatory conditions, there is

Ó 2002 Blackwell Science Ltd 197


198 L. LANGMEAD et al.

little clinical and pharmacological data to support 300 lM in Dulbecco's phosphate buffered saline solu-
these claims. The aim of this work was to investigate tion (PBS) with glucose 5 mmol. A stock solution of
the antioxidant effects in vitro of six herbal remedies xanthine, 5 mmol, was made up by dissolving xanthine
claimed to have bene®t in in¯ammatory bowel disease in 1 M sodium hydroxide and dilution in PBS and stored
and diseases such as rheumatoid arthritis: slippery for up to 1 month; it was added to luminol on the day of
elm, derived from the bark of the slippery elm tree; experiments to a ®nal concentration of 50 lM. Xanthine
fenugreek, an Ayurvedic therapy; Mexican yam, a oxidase was stored at 4 °C and diluted to a concentra-
tropical staple; Devils claw, the root of an African tion of 0.017 U/mL in the ®nal experimental mixture.
¯ower; tormentil, a European ¯ower; and Wei tong 0.34 lM aliquots of 1 mL phycoerythrin were prepared
ning, a traditional Chinese herbal therapy. The ®rst by dissolving the protein precipitate in PBS, centrifuging
®ve remedies are available for sale in health food for 4 min and re-dissolving the pellet in PBS before
stores in the West, although their exact composition removing (NH4)2SO4 on a NAP-5 column (a prepacked
may vary according to proprietary brand. Wei tong disposable chromatography column containing Sepha-
ning is used in Chinese traditional medicine for dex G-25 Medium of DNA grade) with Chelex-treated
treatment of ulcerative colitis. All the preparations PBS; aliquots were stored at 4 °C wrapped in foil. AAPH
contain entire plant extracts rather than puri®ed was prepared on the day of the experiment in Chelex-
chemical entities. treated PBS to give a ®nal cuvette concentration of
We have tested the antioxidant effects of each of these 10 nM.
herbal preparations in two cell-free radical generating To prepare mixtures of herbs for use in the assay
systems, xanthine/xanthine oxidase for superoxide and systems, a single dose of the crude preparation (tablet,
the phycoerythrin degradation assay for the peroxyl capsule contents, liquid or pellet) was crushed and
radical, and in in¯amed colorectal mucosal biopsies, powdered if necessary and dissolved in the smallest
using 5-ASA as a positive control11 and orange juice as possible volume of water (slippery elm, fenugreek,
a nontherapeutic phytic control. Mexican yam, Devil's claw) or DMSO (Wei tong ning)
according to solubility. Any excess particulate matter
was removed by centrifugation. For each herb, the
METHODS supernatant resulting from this procedure was kept as
stock for up to 4 weeks at 4 °C and used in all
Materials
subsequent dilutions. Orange juice was prepared fresh
All chemicals were provided by Sigma Chemical Co. UK on the day of experiment. The juice from an orange was
except for 2,2¢-azobis (2-amidinopropane) dihydrochlo- homogenized and diluted in PBS or Tyrodes medium.
ride (AAPH), which was obtained from Polysciences Dilutions are expressed as parts original stock per
Inc., Warrington, PA, USA. volume of diluent (ppv). 5-ASA was dissolved in 1 M
The sources of herbal remedies were as follows: Na OH on the day of experiments and made up with PBS
slippery elmÐPotter's (Herbal Supplies) Ltd, Wigan, to a 10-mmol stock solution used in all subsequent
UK; fenugreekÐGood `N Natural Manufacturing Corp. dilutions for cell-free experiments. For biopsy incuba-
(USA) for Holland and Barrett, Nuneaton, UK; devils tions a ®nal concentration of 20 mmol 5-ASA was
clawÐBio-Health Ltd, Rochester, Kent, UK; Mexican prepared using Tyrodes medium.
yamÐHigher Nature, Burwash Common, East Sussex,
UK; tormentilÐBioforce (UK) Ltd, Irvine, Scotland,
Patients
UK. Wei tong ning was obtained from the China
Academy of Traditional Chinese Medicine, Beijing, Sigmoid or rectal mucosal biopsies were obtained from
China. patients with active ulcerative colitis undergoing rout-
ine colonoscopy for assessment or surveillance. Diag-
nosis had been con®rmed previously by conventional
Reagents
clinical, colonoscopic and histological criteria. Disease
Luminol was made up as a stock solution, 50 mg/mL, in activity was assessed using clinical17 and sigmoidoscopic
dimethyl sulfoxide (DMSO) and stored at 4 °C for up to scores.18 Details of age, sex, disease extent and current
1 month. On the day of experiments it was diluted to therapy are shown in Table 1. Written informed

Ó 2002 Blackwell Science Ltd, Aliment Pharmacol Ther 16, 197±205


ANTIOXIDANT EFFECTS OF HERBAL THERAPIES IN IBD 199

Table 1. Characteristics of patients with ulcerative colitis used for yield peroxyl radicals.21 Phycoerythrin is a ¯uorescent
in vitro studies of colorectal mucosal biopsies incubated with herbs pigment protein derived from algae; its exposure to
and 5 ASA
oxygen radicals causes zero-order decay in ¯uores-
n ˆ 23 cence. Phycoerythrin was desalted as stated earlier.
Fluorescence of 1 mL 20 nM phycoerythrin with or
Age (years, median[IQR]) 45 [34±51]
Sex, male:female 14:9 without addition of a known dilution of herbal sample
or 5-ASA was measured in a spectro¯uorimeter
Disease extent
(Kontron Instruments, Milan, Italy) with excitation at
Total 11
Sub-total 4 540 nm and emission at 575 nm, thermostated to
Left-sided 8 37 °C and ®tted with an electronic cuvette stirrer.
Disease activity scores
Baseline ¯uorescence in the presence of sample was
Powell-Tuck (median [IQR]) 5 [2±8] measured for 2±3 min before addition of 10 nM AAPH.
Baron sigmoidoscopy score 2 [1±3] Fluorescence was then monitored for 25 min. The rate
Oral treatment of decay of phycoerythrin ¯uorescence was calculated
5-ASA 16 from the slope of the curve of ¯uorescence plotted
Prednisolone 5 against time. The coef®cient of variation of assays was
Azathioprine 4 10.1% (n ˆ 21).20 (Orange juice was not tested using
this assay.)

consent was obtained prior to colonoscopy at which


Mucosal biopsy incubations
8±12 biopsies from macroscopically in¯amed mucosa
were taken. The study was approved by the East London Four to six paired biopsy samples from adjacent areas of
and City Health Authority Ethics Committee. similar macroscopic in¯ammation18 from each individ-
ual patient were placed initially in preoxygenated
incubation medium (Tyrodes medium) before transfer
Xanthine/xanthine oxidase cell-free system
to a tube containing 1 mL of either Tyrodes medium as
The xanthine-xanthine oxidase cell-free system produ- a control, or Tyrodes with added herbal mixtures or
ces superoxide subsequently detected by luminol- orange juice to ®nal dilutions of 1 in 100 ppv (1/1000
dependent chemiluminescence.11, 19 One millilitre of ppv for tormentil), or 20 mmol 5-ASA. Herbal dilutions
preoxygenated luminol + xanthine solution, with were chosen to approximate those likely to be present in
added herbs or orange juice to give ®nal dilutions of the colonic lumen. This was estimated assuming
1 in 50, 1 in 500, 1 in 5000, 1 in 50 000 and 1 in minimal absorption or digestion of phytic constituents
500 000 ppv were added to vials, adjusted to pH 7.4 from the small intestine, and an ileal ef¯uent of about
and precounted. 5-ASA (10±4±10±7 M) was used as a 1 L per day. Tormentil was tested at 1 in 1000 because
positive control. Xanthine oxidase was added to start of its greater potency in the cell-free systems (see below).
the reaction and vials were immediately recounted The 5-ASA concentration chosen was used because it
over 15 min in repeated sequence for 0.5 s per vial in resembles colonic luminal concentration in vivo22 and
an automated LB 953 luminometer (Bertholdt, Bad has previously been demonstrated to inhibit release of
Wildbad, Germany). The ®nal result for each control or ROM from colonic biopsies.11 Biopsies were incubated at
herbal dilution was recorded as the mean value of the 37 °C with a continuous ¯ow of O2 95%/CO2 5%
integral count in counts/s for duplicate vials. The bubbling through the medium. At 20 min, fresh
median coef®cient of variation for assays was 16% medium was exchanged for old. After 40 min, biopsies
(n ˆ 21).20 were washed to remove residual test herb or 5-ASA, and
transferred to precounted scintillation vials containing
1 mL 300 lM luminol with 5 mmol glucose, pH 7.4.
Phycoerythrin degradation cell-free assay
Vials were immediately counted for 4 mins each in the
Free radicals were generated using AAPH, a chemical LB953 luminometer. After assay, biopsies were blot-
that decomposes at a temperature-controlled rate to dried and weighed. Chemiluminescence was recorded as
form carbon-centred radicals that react with oxygen to the mean for paired biopsies expressed as counts/min/mg

Ó 2002 Blackwell Science Ltd, Aliment Pharmacol Ther 16, 197±205


200 L. LANGMEAD et al.

Figure 1. Dose±response curves for inhibitory effects of herbs, orange juice and 5-aminosalicylic acid (5-ASA) on chemiluminescence
produced by oxygen radicals released by the xanthine/xanthine oxidase system. Dilution of herbs and orange juice is expressed as parts
per volume (ppv) and 5-ASA concentration in mols (n ³ 3 for each agent).

Ó 2002 Blackwell Science Ltd, Aliment Pharmacol Ther 16, 197±205


ANTIOXIDANT EFFECTS OF HERBAL THERAPIES IN IBD 201

tissue weight, after subtraction of background. The


In¯amed colorectal biopsies
coef®cient of variation of chemiluminescence counts for
paired biopsies was 47% (n ˆ 30).20 In comparison with controls, chemiluminescence was
signi®cantly reduced in biopsies incubated with 1 in
100 dilutions of slippery elm (P < 0.02), fenugreek
Calculations and statistics
(P < 0.05), Devil's claw (P < 0.05), and Wei tong
For all assays, the effect of each herb or 5-ASA was ning (P < 0.02), and 1 in 1000 dilution of tormentil
expressed as a percentage of the mean result of the (P < 0.05). There was no signi®cant antioxidant effect
control pair for that experiment. Results were com- with Mexican yam or orange juice (Figure 3).
pared using the Wilcoxon signed ranks test for paired
data using 2-tailed P-values and taking < 0.05 as
DISCUSSION
statistically signi®cant. All comparisons were planned
prospectively, therefore no correction was made for In previous studies, we have used cell-free and mucosal
multiple comparisons.23 Dose±response curves were biopsy chemiluminescence-based methods alone for
drawn using linear logistic regression curves for the assessing the antioxidant effects of conventional and
mean values for three experiments for each herb at potentially novel drugs for in¯ammatory bowel dis-
each dilution. The IC50 was obtained from the line of ease.11, 24 In the present work we have also employed
best ®t. Coef®cients of variation were calculated using a ¯uorescence-based cell-free assay. With the two cell-
the method of Bland.20 free systems, scavenging of both superoxide and
peroxyl can be assessed. While the cell-free techniques
have the advantages of being technically straightfor-
RESULTS ward, readily available, highly reproducible, speci®c in
relation to the radical generated, and allowing dose±
Xanthine/xanthine oxidase cell-free system
response curves to be generated, the use of a tissue-
Slippery elm, Mexican yam, Devil's claw, tormentil, based method is likely to provide a closer model of
Wei tong ning and 5-ASA all had dose-dependent what may occur in vivo. The mucosal luminol-based
antioxidant effects (Figure 1). Fenugreek and orange chemiluminescence assay sensitively but nonspeci®cal-
juice had no effects except undiluted (Figure 1). The ly detects production of multiple different ROMs, of
potency for each herb, as assessed by the dilution that which the predominant species in active ulcerative
produced 50% inhibition of ROM detection (IC50), colitis are probably hypochlorite, hydrogen peroxide
ranged between 10±4 for Mexican yam and 10±6 for and hydroxyl ion as well as superoxide.24 The results
tormentil (Table 2). obtained with each assay method therefore comple-
ment each other: as indicated below, however they do
not precisely mimic each other.
Phycoerythrin degradation assay
In vivo, antioxidants may exert their activity at
All the herbs and 5-ASA had dose-dependent peroxyl- several different points in the pathways of oxidant
radical scavenging effects (Figure 2). The IC50 for this metabolism.25, 26 Prevention of radical generation may
effect varied between 10±2 for Mexican yam and 10±5 be achieved at a tissue level as a result of down-
for tormentil (Table 2). regulation of recruitment and/or activation of neu-

Table 2. IC50 for herbs and 5 ASA in


IC50 SE FG DC MY T WTN 5 ASA
xanthine/xanthine oxidase and
phycoerythrin degradation assays X/XO 3 ´ 10)4 N/A 3 ´ 10)4 3 ´ 10)4 1 ´ 10±6 5 ´ 10)4 10)5 M
PE 1 ´ 10)3 1 ´ 10)3 7 ´ 10)3 8 ´ 10)2 1 ´ 10)5 1 ´ 10)3 10)5 M

The concentration (expressed as dilution in parts per volume (ppv) for herbs and mols for 5
ASA) to produce 50% inhibition of ROM detection (IC50) is shown for the xanthine/xanthine
oxidase system (X/XO) (Figure 1) and the phycoerythrin degradation assay (PE) (Figure 2)
(n ³ 3 for each agent). SE ˆ slippery elm, FG ˆ fenugreek, DC ˆ devil's claw, MY ˆ Mexican
yam, T ˆ tormentil, WTN ˆ Wei tong ning, 5 ASA ˆ 5-aminosalicylic acid. Results for
orange juice are not shown because no inhibition was seen.

Ó 2002 Blackwell Science Ltd, Aliment Pharmacol Ther 16, 197±205


202 L. LANGMEAD et al.

Figure 2. Dose±response curves for inhibitory effects of herbs and


5-aminosalicylic acid (5-ASA) on phycoerythrin degradation
produced by peroxyl radicals released by the thermal decomposi-
tion of AAPH. Herb dilution is expressed as parts per volume (ppv)
and 5-ASA concentration in mols (n ³ 3 for each agent).

Ó 2002 Blackwell Science Ltd, Aliment Pharmacol Ther 16, 197±205


ANTIOXIDANT EFFECTS OF HERBAL THERAPIES IN IBD 203

Figure 3. Effects of herbs and orange juice


at 1 in 100 dilution (except tormentil ˆ 1
in 1000) and 5-aminosalicylic acid
20 mmol (5-ASA) on release of reactive
oxygen metabolites from in¯amed
colorectal mucosal biopsies measured by
luminol-ampli®ed chemiluminescence after
40 min incubation. Results are expressed
as percentage of chemiluminescence
produced by control biopsies incubated in
inert vehicle. Median, IQR and range are
shown.*P < 0.02, **P < 0.05 compared
with controls, n ³ 5 for each.

trophils or monocytes. At a cellular level activation of bene®cial effect on in¯amed intestines. Fenugreek
in¯ammatory cells may be reduced by blockade of contains steroidal saponins, which form the basis for
membrane receptors or inhibition of intracellular physiological steroid production and might be able to
metabolic pathways. Prevention of the activity of in¯uence the local in¯ammatory response.27±29
radicals after their generation and release can occur Mexican yam is a tropical perennial whose starch-rich
as a result of scavenging by antioxidants. Protection of tuberized root is a food staple in the areas in which it
target tissues from radical attack from the lumen of the grows. Like fenugreek, it contains saponins in the form
intestine could also be a result of enhancement of of dioscorea, a steroid extract used in commercial
physico±chemical barriers, for example by increased steroid synthesis. Mexican yam is used by herbalists
mucus production. The cell-free methods used in the for the treatment of menstrual irregularities as well as
present studies provide information about superoxide joint and gut in¯ammation.
and peroxyl scavenging, while the mucosal biopsy Devil's claw (Harpagophytum procumbens) is a ¯ower-
results give an indication of the net effects of the herbs ing plant native to southern Africa. The tuberized
tested on tissue oxidant activity without elucidating secondary roots are used in parts of Africa for liver and
their mechanism. stomach ailments and for joint pains; it is said to have
We have employed these three assays to investigate analgesic and anti-in¯ammatory properties. Uncon-
the antioxidant effects of six widely used herbal trolled studies in rheumatic and degenerative joint
preparations. disease have shown an improvement in mobility and
Slippery elm bark from the slippery elm, or red elm tree reduction of pain.30 Ex-vivo and in vitro studies failed
native to North America, is claimed to have ``soothing'' to show any effect on eicosanoid production in whole
properties in in¯ammation of the gastrointestinal blood,31, 32 suggesting that the anti-in¯ammatory
tract. It is popular among in¯ammatory bowel disease effects (if any) of devil's claw are mediated through
patients in the UK.6 other mechanisms. Extracts of devil's claw contain
Fenugreek is an aromatic herb that produces Methi ¯avonoids, which are proven free radical scaven-
seeds, which are used in Indian cookery for their gers,33, 34 and plant phenols, which are able to donate
distinctive pungent aroma. In traditional Ayurvedic hydrogen to oxygen radicals to form stable inert
medicine, fenugreek, like slippery elm, is said to have a compounds.35, 36

Ó 2002 Blackwell Science Ltd, Aliment Pharmacol Ther 16, 197±205


204 L. LANGMEAD et al.

Tormentil (Potentilla tormentilla) is a member of the Further exploration of the antioxidant chemistry of
rose family that grows wild all over Europe. The root is herbal extracts would require separation and puri®ca-
thick and red on the inside giving rise to the herb's tion of the multiple individual potentially bioactive
alternative name, bloodroot. It is said to be effective in components of each. However, in the absence of
the treatment of diarrhoea and bowel in¯ammation. controlled trials indicating their ef®cacy in in¯amma-
Tormentil contains a high concentration of tannins tory bowel disease or other in¯ammatory diseases, this
known to have a potent superoxide-scavenging time-consuming and expensive exercise may be prema-
effect.37, 38 ture and contradicts the concept of use of whole plant
Traditional Chinese medicine uses both physical (e.g. extracts by herbalists.
acupuncture) and herbal treatments to redress imbal- The results reported here indicate that a range of
ances in energy meridians said to be associated with widely used herbal preparations have antioxidant effects
disease. The remedy we have tested, wei tong ning, is both in cell-free and mucosal biopsy assay systems.
prescribed by Chinese herbalists for treatment of Consideration should be given to formal evaluation
patients with peptic ulceration and other intestinal in vivo of the therapeutic potential of slippery elm,
in¯ammatory disorders. fenugreek, devil's claw, tormentil and wei tong ning in
All the herbs tested are likely to contain numerous patients with in¯ammatory bowel disease and other
biologically active and, speci®cally, antioxidant com- chronic in¯ammatory conditions.
pounds. These include vitamins C and E, in varying
concentrations, both naturally and in some prepara-
REFERENCES
tions as preservative additives. To address the fact that
many vegetable and other food products also contain 1 Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative
potentially biologically active components and yet are medicine use in the United States, 1990±97: results of a
follow-up national survey [see comments]. JAMA 1998;
not claimed to have any therapeutic bene®ts, we have
280(18): 1569±75.
used orange juice as a phytic control. 2 Hilsden RJ, Scott CM, Verhoef MJ. Complementary medicine
Our results have shown that, like 5-ASA, slippery elm, use by patients with in¯ammatory bowel disease [see com-
devil's claw, tormentil and wei tong ning are antioxid- ments]. Am J Gastroenterol 1998; 93(5): 697±701.
ant in all three assay systems used. Fenugreek failed to 3 Moody GA, Eaden JA, Bhakta P, et al. The role of complementary
medicine in European and Asian patients with in¯ammatory
scavenge superoxide except at high concentrations, but
bowel disease. Public Health 1998; 112(4): 269±71.
did have peroxyl-radical scavenging effects and reduced 4 Moser G, Tillinger W, Sachs G, et al. Relationship between the
release of ROMs from in¯amed mucosa. It seems likely use of unconventional therapies and disease-related concerns:
that different components of fenugreek are responsible a study of patients with in¯ammatory bowel disease.
for its con¯icting effects. The observation that Mexican J Psychosom Res 1996; 40(5): 503±9.
yam is a scavenger in cell-free systems but has no effect 5 Hilsden RJ, Meddings JB, Verhoef MJ. Complementary and
alternative medicine use by patients with in¯ammatory bowel
in biopsies could be explained by failure of its antioxid-
disease: An Internet survey. Can J Gastroenterol 1999; 13(4):
ant component(s) to penetrate mucosal tissue during 327±32.
the short incubation period used. Alternatively, it is 6 Langmead L, Chitnis M, Rampton D. Complementary
possible that Mexican yam contains substances that therapies in GI patients: who uses them and why? Gut 2000;
have pro-in¯ammatory effects in tissue that are not 46(Suppl. II): A22(Abstract).
7 Simmonds NJ, Rampton DS. In¯ammatory bowel diseaseÐa
detectable in cell-free assays.
radical view. Gut 1993; 34(7): 865±8.
That orange juice fails to have an antioxidant effect 8 Grisham MB. Oxidants and free radicals in in¯ammatory
except at nearly neat concentrations is perhaps surpri- bowel disease. Lancet 1994; 344(8926): 859±61.
sing, given its vitamin C content. However, it suggests 9 Harris ML, Schiller HJ, Reilly PM, et al. Free radicals and other
that the potency shown by the herbal remedies tested reactive oxygen metabolites in in¯ammatory bowel disease:
may be therapeutically signi®cant and adds weight to cause, consequence or epiphenomenon? Pharmacol Ther
1992; 53(3): 375±408.
the claim that particular herbs may have antioxidant
10 Middleton SJ, Shorthouse M, Hunter JO. Increased nitric oxide
constituents and actions over and above those seen in synthesis in ulcerative colitis [see comments]. Lancet 1993;
many common foods. This conclusion is supported by 341(8843): 465±6.
the observation that they behave similarly to the 11 Simmonds NJ, Millar AD, Blake DR, et al. Antioxidant effects
puri®ed pharmacological agent, 5-ASA. of aminosalicylates and potential new drugs for in¯ammatory

Ó 2002 Blackwell Science Ltd, Aliment Pharmacol Ther 16, 197±205


ANTIOXIDANT EFFECTS OF HERBAL THERAPIES IN IBD 205

bowel disease: assessment in cell-free systems and in¯amed 26 Bauer V, Bauer F. Reactive oxygen species as mediators of
human colorectal biopsies. Aliment Pharmacol Ther 1999; tissue protection and injury. Gen Physiol Biophys 1999; 18:
13(3): 363±72. 7±14.
12 Yamada T, Grisham MB. Role of neutrophil-derived oxidants in 27 Sauvaire Y, Baissac Y, Leconte O, et al. Steroid saponins from
the pathogenesis of intestinal in¯ammation. Klin Wochenschr fenugreek and some of their biological properties. Adv Exp
1991; 69(21±23): 988±94. Med Biol 1996; 405: 37±46.
13 Keshavarzian A, Fields JZ. A radical perspective on ulcerative 28 Petit PR, Sauvaire YD, Hillaire-Buys DM, et al. Steroid sapo-
colitis [editorial; comment]. J Gastroenterol Hepatol 1995; nins from fenugreek seeds: extraction, puri®cation, and
10(2): 208±9. pharmacological investigation on feeding behavior and
14 Levin KE, Pemberton JH, Phillips SF, et al. Role of oxygen free plasma cholesterol. Steroids 1995; 60(10): 674±80.
radicals in the etiology of pouchitis. Dis Colon Rectum 1992; 29 Dawidar AM, Saleh AA, Elmotei SL. Steroid sapogenin
35(5): 452±6. constituents of fenugreek seeds. Planta Med 1973; 24(4):
15 Jarnerot G, Strom M, Danielsson A, et al. Allopurinol in 367±70.
addition to 5-aminosalicylic acid based drugs for the main- 30 Wegener T. [Therapy of degenerative diseases of the muscu-
tenance treatment of ulcerative colitis. Aliment Pharmacol loskeletal system with South African devil's claw (Harpago-
Ther 2000; 14(9): 1159±62. phytum procumbens DC)]. Wien Med Wochenschr 1999;
16 Emerit J, Pelletier S, Tosoni-Verlignue D, et al. Phase II trial of 149(8±10): 254±7.
copper zinc superoxide dismutase (CuZnSOD) in treatment of 31 Whitehouse LW, Znamirowska M, Paul CJ. Devil's Claw
Crohn's disease. Free Radic Biol Med 1989; 7(2): 145±9. (Harpagophytum procumbens): no evidence for anti-in¯amma-
17 Powell-Tuck J, Day DW, Buckell NA, et al. Correlations tory activity in the treatment of arthritic disease. Can Med
between de®ned sigmoidoscopic appearances and other Assoc J 1983; 129(3): 249±51.
measures of disease activity in ulcerative colitis. Dig Dis Sci 32 Moussard C, Alber D, Toubin MM, et al. A drug used in tra-
1982; 27(6): 533±7. ditional medicine, Harpagophytum procumbens: no evidence for
18 Baron J, Connell A, Lennard-Jones A. Variation between NSAID-like effect on whole blood eicosanoid production in
observers in describing mucosal appearances in proctocolitis. human. Prostaglandins Leukot Essent Fatty Acids 1992;
BMJ 1964; 1: 189±92. 46(4): 283±6.
19 Millar AD, Rampton DS, Chander CL, et al. Evaluating the 33 Choi HY, Jhun EJ, Lim BO, et al. Application of ¯ow injec-
antioxidant potential of new treatments for in¯ammatory bowel tionÐchemiluminescence to the study of radical scavenging
disease using a rat model of colitis. Gut 1996; 39(3): 407±15. activity in plants. Phytother Res 2000; 14(4): 250±3.
20 Bland J. Clinical measurementÐrepeatability and precision 34 Dugas AJ Jr, Castaneda-Acosta J, Bonin GC, et al. Evaluation
measurement. An Introduction to Medical Statistics, 3rd edn. of the total peroxyl radical-scavenging capacity of ¯avonoids:
Oxford: Oxford University Press, 1991: 267±8. structure±activity relationships. J Nat Prod 2000; 63(3):
21 Glazer AN. Phycoerythrin ¯uorescence-based assay for 327±31.
reactive oxygen species. Meth Enzymol 1990; 186: 161±8. 35 Liu Z, Ma LP, Zhou B, et al. Antioxidative effects of green tea
22 Staerk Laursen L, Stokholm M, Bukhave K, et al. Disposition of polyphenols on free radical initiated and photosensitized per-
5-aminosalicylic acid by olsalazine and three mesalazine oxidation of human low density lipoprotein. Chem Phys Lipids
preparations in patients with ulcerative colitis: comparison of 2000; 106(1): 53±63.
intraluminal colonic concentrations, serum values, and 36 Sawa T, Nakao M, Akaike T, et al. Alkylperoxyl radical-scav-
urinary excretion. Gut 1990; 31(11): 1271±6. enging activity of various ¯avonoids and other phenolic
23 Perneger TV. What's wrong with Bonferroni adjustments [see compounds: implications for the anti-tumor-promoter effect of
comments]. BMJ 1998; 316(7139): 1236±8. vegetables. J Agric Food Chem 1999; 47(2): 397±402.
24 Simmonds NJ, Allen RE, Stevens TR, et al. Chemilumines- 37 Bos MA, Vennat B, Meunier MT, et al. Procyanidins from tor-
cence assay of mucosal reactive oxygen metabolites in mentil: antioxidant properties towards lipoperoxidation and
in¯ammatory bowel disease. Gastroenterology 1992; 103(1): anti-elastase activity. Biol Pharm Bull 1996; 19(1): 146±8.
186±96. 38 Vennat B, Bos MA, Pourrat A, et al. Procyanidins from
25 Hensley K, Robinson KA, Gabbita SP, et al. Reactive oxygen tormentil: fractionation and study of the anti-radical activity
species, cell signaling, and cell injury. Free Radic Biol Med towards superoxide anion. Biol Pharm Bull 1994; 17(12):
2000; 28(10): 1456±62. 1613±5.

Ó 2002 Blackwell Science Ltd, Aliment Pharmacol Ther 16, 197±205

You might also like